Information Journal Paper
APA:
Copy. (2017). Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction. BIOCHEMICAL PHARMACOLOGY, 131(-), 16-28. SID. https://sid.ir/paper/744662/en
Vancouver:
Copy. Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction. BIOCHEMICAL PHARMACOLOGY[Internet]. 2017;131(-):16-28. Available from: https://sid.ir/paper/744662/en
IEEE:
Copy, “Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction,” BIOCHEMICAL PHARMACOLOGY, vol. 131, no. -, pp. 16–28, 2017, [Online]. Available: https://sid.ir/paper/744662/en